Table 5.
Hazard ratios of primary endpoints in elderly patients
VA abandonment | All-cause mortality | Maturation failure | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | OR (95% CI) | P value | |
Age | – | – | 1.08 (1.05–1.12) | < 0.001 | ||
Hemoglobin | 1.41 (1.11–1.81) | 0.006 | – | – | ||
Albumin | – | – | – | – | 2.61 (1.6.0–4.25) | < 0.001 |
VA type (ref. RC AVF) | 0.033 | 0.003 | 0.010 | |||
BC AVF | 0.97 (0.35–2.68) | 0.955 | 1.54 (0.92–2.57) | 0.102 | 0.81 (0.47–1.42) | 0.464 |
AVG | 2.77 (1.22–6.27) | 0.015 | 2.65 (1.52–4.63) | 0.001 | 0.24 (0.09–0.60) | 0.002 |
PVD | – | – | 2.39 (1.13–5.06) | 0.023 | ||
BA diameter | 0.59 (0.37–0.93) | 0.024 | – | – |
Adjusted for age, sex, BMI, systolic pressure, Hemoglobin, cholesterol, albumin, calcium, phosphorus, DM, CAD, PVD, CVD, CHF, VA type, history of CVC, duplex U/S findings (Brachial a. diameter, Brachial a. flow, Needling site diameter, Needling site flow)
VA vascular access, BMI body mass index, CHF congestive heart failure, BA brachial artery, SBP systolic blood pressure, PVD peripheral vascular disease, HR hazard ratio, CI confidence index, OR odds ratio